Manufacturing Cellular Therapies: Challenges, Solutions and Creating Synergy for Success

Workshop explores perspectives from across the cellular therapy industry

Contact our team to start building your solution

Join Be The Match BioTherapies® and AABB® in San Antonio this fall for an interactive workshop and collaborative learning opportunity that will unpack real-world scenarios highlighting the challenges of implementing cellular therapies across various settings and business models.

The workshop will explore the perspectives of hospitals, blood centers and small startup companies with both centralized and decentralized manufacturing models. Join us for an afternoon of collaborative learning and deep discussion with world-renowned faculty.

Manufacturing Cellular Therapies: Challenges, Solutions and Creating Synergy for Success
Friday, Oct. 18, 2019
Noon–5:30 p.m.
Grand Hyatt San Antonio
Texas Ballroom AB
San Antonio, Texas

Register for the workshop here.

Noon–1 p.m.

Opening Session: Manufacturing Challenges in Implementing Cellular Therapy Services

This fireside chat will address the challenges and hurdles inherent to working in the cell and gene therapy industry. Participants will discuss successes, setbacks, and lessons learned as a result of sustained industry experience.

Moderators:

Magali Fontaine, MD, PhD
Professor, Department of Pathology and Medicine
University of Maryland School of Medicine
Chair, Workshop Planning Committee

Amy Hines, RN, BSN
Director, Collection Experience
National Marrow Donor Program®/Be The Match®

Panelists:

Joseph McGuirk, DO
Professor, Hematology-Oncology
Division Director, Hematologic Malignancies and Cellular Therapeutics
Medical Director, Blood and Marrow Transplant
The University of Kansas Medical Center

Robert Tressler, PhD, MS
Vice President, Laboratories
San Diego Blood Bank

John McMannis, PhD
Executive Vice President, Manufacturing
Mesoblast, Inc.

1–2 p.m.

Lunch

2–2:45 p.m.

Plenary Session: Inroads to Response and Resistance in CAR-T Cell Therapy

Moderator:

Mark Flower
Senior Director, Sales and New Business Development
Be The Match BioTherapies®

Speaker:

Joseph Fraietta, PhD
Director, Solid Tumor Immunotherapy Laboratory
Center for Advanced Cellular Therapeutics, University of Pennsylvania

2:45–3:15 p.m.

Mechanisms of Tumor Escape from CAR-T Cell Therapy: Challenges and Solutions

Moderator:

Mark Flower
Senior Director, Sales and New Business Development
Be The Match BioTherapies®

Speaker:

Mohamad Hamieh
Research Associate
Dr. Michel Sadelain Lab Center for Cell Engineering, Memorial Sloan Kettering Cancer Center

3:15–3:45 p.m.

The Therapeutic Use of Extracellular Vesicles by MSC: Improving Right Ventricular Function and Pulmonary Fibrosis with MSC Derived Exosomes

Speaker:

Luis A. Ortiz, MD
Professor, Department of Environmental and Occupational Medicine, Graduate School of Public Health
Professor, Department of Medicine

University of Pittsburgh

3:45–4:00 p.m.

Break

4–5:30 p.m.

Breakout Session A: New Cells on the Block

This deep-dive session will highlight the latest scientific advancements in cellular-derived therapeutics, including exosomes, microparticles and emerging devices for delivery.

Moderator:

Magali Fontaine, MD, PhD
Professor, Department of Pathology and Medicine
University of Maryland School of Medicine

Speakers:

Patrick Hanley, PhD

Director, Cellular Therapy Laboratory
Children’s National Medical Center
Assistant Professor, Pediatrics
George Washington University

Presentation: Optimizing the Manufacture of MSCs and T cells for Phase 1 Clinical Trials

Aisha Khan, PhDc, MSc, MBA
Executive Director, Laboratory Operations
Miller School of Medicine, The University of Miami

Presentation: Pre-Clinical and Clinical Cell Manufacturing

Andrew Rhim, MD
Assistant Professor
MD Anderson Cancer Center, The University of Texas

Presentation: The Role of Blood Banks in Personalized Cancer Care

Breakout Session B: Ground-level Synergies for Novel Cell Therapies

This session will cover current strategies for donor selection, consent, and characterization as well as the latest advancements in the processing of source material for autologous and allogenic cell therapies.

Moderator:

Christie Malone, MT (ASCP) SBB
Corporate Account Executive
GenCure Biomanufacturing

Panelists:

John Armitage, MD
Chief Executive Officer and President
Oklahoma Blood Institute

Olive Sturtevant, MT(ASCP)SBB, CQA
Administrative Director
Connell & O’Reilly Families Cell Manipulation Core Facility, Dana Farber Cancer Institute

Timothy Sheehy
Director, Quality and Regulatory Affairs
Versiti Blood Center

Hanh Khuu, MD
Medical Officer
US FDA Center for Biologics Evaluation and Research (CBER), Office of Tissues and Advanced Therapies

5:30 p.m.

Program Adjourns

6 p.m.

Cellular Therapies Network Reception 

Register today for the pre-meeting workshop, “Manufacturing Cellular Therapies: Challenges, Solutions and Creating Synergy for Success,” today!